Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Medical ventilator Stories

2012-03-27 23:03:46

Despite being 50-year-old technology, bag valve masks are still the standard of care in pre-hospital resuscitation. James Evans, President of AutoMedx, discusses the dangers and shortcomings of manual resuscitation using BVMs. (PRWEB) March 27, 2012 An estimated 15.7 million medical related 911 calls are made in the US annually. For calls where a patient is not breathing, EMS (Emergency Medical Services) personnel typically utilize a bag valve mask (BVM) resuscitator. BVMs have been the...

2012-03-19 06:25:13

JERUSALEM and NEEDHAM, Mass., March 19, 2012 /PRNewswire/ -- Oridion (SIX Swiss Exchange: ORIDN), creator of the Integrated Pulmonary Index(TM), one of the Smart Capnography(TM) family of decision-support solutions, today announced results of an attendee survey conducted at the October 2011 annual meeting of the American Society for Anesthesiologists (ASA) conference in Chicago. Respondents showed a clear preference for monitoring ventilation using capnography over other options. Results of...

2012-02-08 06:45:00

WARRINGTON, Pa., Feb. 8, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that it has entered into a definitive agreement with Lacey Manufacturing, a unit of Precision Engineered Products, LLC to manufacture and supply product for the commercial introduction of AFECTAIR®. AFECTAIR was recently cleared for commercialization in the United States and...

2012-02-06 22:22:31

More and more people being cared for on ventilators are conscious during the treatment, but what is it like to be fully conscious without being able to communicate with the world around you? A thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden, has lifted the lid on a world of panic, breathlessness and unheard pain. It has been far more common since the beginning of the 21st century for patients to be conscious during ventilator treatment. There are medical...

2012-02-02 06:45:00

WARRINGTON, Pa., Feb. 2, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced AFECTAIR® is now registered with the Food and Drug Administration (FDA) and is cleared to be marketed in the United States. AFECTAIR is a proprietary patient interface technology that simplifies delivery of aerosolized medications to patients requiring ventilator support. "We are...

2012-01-12 19:00:00

MURRYSVILLE, Pa., Jan. 12, 2012 /PRNewswire/ -- Respironics, Inc. announced today that it has completed notifying customers of a voluntary recall of 52 Trilogy Model 100 ventilators in the United States and has confirmed that 51 have already been removed from use. The recall was initiated on October 11, 2011 to address a manufacturing issue that may have affected these ventilators. Respironics received no reports of ventilator malfunctions, failures or injuries related to this issue. The...

2011-12-22 07:00:00

SAN DIEGO, Dec. 22, 2011 /PRNewswire/ -- CareFusion issued the following update regarding the voluntary recall of AVEA® ventilators it initiated in September. The FDA has now classified this action as a Class I recall. There is no change to the remediation plans previously announced by the company and CareFusion is actively remediating the hardware on affected units. The recall affects AVEA ventilators and spare parts manufactured between March 1, 2009 and June 30, 2011 and...

2011-12-06 07:15:00

WARRINGTON, Pa., Dec. 6, 2011 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) today released new data showing that use of AFECTAIR® resulted in as much as a 70 percent reduction in the amount of nitric oxide required to deliver the desired dose of the therapeutic gas when compared with current standard of care (SoC) (p < 0.001). Nitric oxide is a costly medical gas frequently used for the treatment of pulmonary hypertension in newborn infants. AFECTAIR, the...

2011-11-08 07:15:00

WARRINGTON, Pa., Nov. 8, 2011 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that new data supporting AFECTAIR(TM), the Company's newest product candidate, was presented at the American Association for Respiratory Care (AARC) Congress 2011, internationally recognized as the most relevant medical meeting dedicated to advancing the science and practice of respiratory care. AFECTAIR has been developed by Discovery Labs to simplify the delivery of inhaled...

2011-11-04 12:00:00

SAN DIEGO, Nov. 4, 2011 /PRNewswire/ -- CareFusion today announced the CareFusion Ventilation System, combining its industry leading ventilators with new interoperability and analytics software to better address clinical and operational challenges in patient care. The CareFusion Ventilation System includes the company's AVEA®, VELA® and EnVeTM ventilators and adds two new applications: CareFusion Respiratory Documentation Application: A handheld,...